Evidence map›Paper›PMID 32210133›Full record

ArticleMicroorganisms2020

Formate Utilization by the Crenarchaeon

Ipek Ergal, Barbara Reischl, Benedikt Hasibar, Lokeshwaran Manoharan, Aaron Zipperle, Günther Bochmann, Werner Fuchs, Simon K-M R Rittmann

Abstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Formate-driven efficient pyruvate biosynthesis inSynthetic and systems biotechnology · 2026
    Article
  2. FormatotrophicSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ipek ErgalArchaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Universität Wien, 1090 Wien, Austria.
Barbara ReischlArchaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Universität Wien, 1090 Wien, Austria.
Benedikt HasibarDepartment IFA Tulln, Institute for Environmental Biotechnology, University of Natural Resources and Life Sciences, 1180 Wien, Austria.ORCID 0000-0002-2628-8685
Lokeshwaran ManoharanArchaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Universität Wien, 1090 Wien, Austria.ORCID 0000-0001-9751-5745
Aaron ZipperleArchaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Universität Wien, 1090 Wien, Austria.ORCID 0000-0001-8578-8797
Günther BochmannDepartment IFA Tulln, Institute for Environmental Biotechnology, University of Natural Resources and Life Sciences, 1180 Wien, Austria.
Werner FuchsDepartment IFA Tulln, Institute for Environmental Biotechnology, University of Natural Resources and Life Sciences, 1180 Wien, Austria.
Simon K-M R RittmannArchaea Physiology & Biotechnology Group, Department of Functional and Evolutionary Ecology, Universität Wien, 1090 Wien, Austria.ORCID 0000-0002-9746-3284

Funding

Österreichische Forschungsförderungsgesellschaft 853618Österreichische Forschungsförderungsgesellschaft 859293
6 · The paper itself

Abstract

Formate is one of the key compounds of the microbial carbon and/or energy metabolism. It owes a significant contribution to various anaerobic syntrophic associations, and may become one of the energy storage compounds of modern energy biotechnology. Microbial growth on formate was demonstrated for different bacteria and archaea, but not yet for species of the archaeal phylum Crenarchaeota. Here, we show that

Indexed as

anaerobeArchaeaCrenarchaeotaformaldehydemetabolismmicrobial physiologyone-carbon

Identifiers

PMID32210133
PMCPMC7143981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.